121 related articles for article (PubMed ID: 37845743)
1. Elevated glycosylation of CD36 in platelets is a risk factor for oxLDL-mediated platelet activation in type 2 diabetes.
Agarwal S; Saha S; Ghosh R; Sarmadhikari D; Asthana S; Maiti TK; Khadgawat R; Guchhait P
FEBS J; 2024 Jan; 291(2):376-391. PubMed ID: 37845743
[TBL] [Abstract][Full Text] [Related]
2. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein.
Chen K; Febbraio M; Li W; Silverstein RL
Circ Res; 2008 Jun; 102(12):1512-9. PubMed ID: 18497330
[TBL] [Abstract][Full Text] [Related]
3. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein.
Nergiz-Unal R; Lamers MM; Van Kruchten R; Luiken JJ; Cosemans JM; Glatz JF; Kuijpers MJ; Heemskerk JW
J Thromb Haemost; 2011 Sep; 9(9):1835-46. PubMed ID: 21696539
[TBL] [Abstract][Full Text] [Related]
4. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A.
Korporaal SJ; Van Eck M; Adelmeijer J; Ijsseldijk M; Out R; Lisman T; Lenting PJ; Van Berkel TJ; Akkerman JW
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2476-83. PubMed ID: 17761940
[TBL] [Abstract][Full Text] [Related]
5. Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade.
Magwenzi S; Woodward C; Wraith KS; Aburima A; Raslan Z; Jones H; McNeil C; Wheatcroft S; Yuldasheva N; Febbriao M; Kearney M; Naseem KM
Blood; 2015 Apr; 125(17):2693-703. PubMed ID: 25710879
[TBL] [Abstract][Full Text] [Related]
6. CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding.
Jay AG; Chen AN; Paz MA; Hung JP; Hamilton JA
J Biol Chem; 2015 Feb; 290(8):4590-4603. PubMed ID: 25555908
[TBL] [Abstract][Full Text] [Related]
7. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.
Yang M; Kholmukhamedov A; Schulte ML; Cooley BC; Scoggins NO; Wood JP; Cameron SJ; Morrell CN; Jobe SM; Silverstein RL
Blood Adv; 2018 Nov; 2(21):2848-2861. PubMed ID: 30381401
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.
Wraith KS; Magwenzi S; Aburima A; Wen Y; Leake D; Naseem KM
Blood; 2013 Jul; 122(4):580-9. PubMed ID: 23699602
[TBL] [Abstract][Full Text] [Related]
9. Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation.
Badrnya S; Schrottmaier WC; Kral JB; Yaiw KC; Volf I; Schabbauer G; Söderberg-Nauclér C; Assinger A
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):571-80. PubMed ID: 24371083
[TBL] [Abstract][Full Text] [Related]
10. Sulfo-N-succinimidyl oleate (SSO) inhibits fatty acid uptake and signaling for intracellular calcium via binding CD36 lysine 164: SSO also inhibits oxidized low density lipoprotein uptake by macrophages.
Kuda O; Pietka TA; Demianova Z; Kudova E; Cvacka J; Kopecky J; Abumrad NA
J Biol Chem; 2013 May; 288(22):15547-55. PubMed ID: 23603908
[TBL] [Abstract][Full Text] [Related]
11. The Role of CD36/GPIV in Platelet Biology.
Bendas G; Schlesinger M
Semin Thromb Hemost; 2024 Mar; 50(2):224-235. PubMed ID: 37192651
[TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients.
Janabi M; Yamashita S; Hirano K; Sakai N; Hiraoka H; Matsumoto K; Zhang Z; Nozaki S; Matsuzawa Y
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1953-60. PubMed ID: 10938017
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidemia-associated atherogenic oxidized lipids induce platelet hyperactivity through phospholipase Cγ2-dependent reactive oxygen species generation.
Berger M; Wraith K; Woodward C; Aburima A; Raslan Z; Hindle MS; Moellmann J; Febbraio M; Naseem KM
Platelets; 2019; 30(4):467-472. PubMed ID: 29733744
[TBL] [Abstract][Full Text] [Related]
14. Increased uptake of oxLDL does not exert lipotoxic effects in insulin-secreting cells.
Ma Z; Ketelhuth DFJ; Wirström T; Ohki T; Forteza MJ; Wang H; Grill V; Wollheim CB; Björklund A
J Mol Endocrinol; 2019 May; 62(4):159-168. PubMed ID: 30917339
[TBL] [Abstract][Full Text] [Related]
15. Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation.
Rios FJ; Koga MM; Ferracini M; Jancar S
PLoS One; 2012; 7(5):e36632. PubMed ID: 22570732
[TBL] [Abstract][Full Text] [Related]
16. Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions.
Yang M; Cooley BC; Li W; Chen Y; Vasquez-Vivar J; Scoggins NO; Cameron SJ; Morrell CN; Silverstein RL
Blood; 2017 May; 129(21):2917-2927. PubMed ID: 28336528
[TBL] [Abstract][Full Text] [Related]
17. Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A.
Berger M; Raslan Z; Aburima A; Magwenzi S; Wraith KS; Spurgeon BEJ; Hindle MS; Law R; Febbraio M; Naseem KM
Haematologica; 2020 Mar; 105(3):808-819. PubMed ID: 31289200
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3.
Wintergerst ES; Jelk J; Rahner C; Asmis R
Eur J Biochem; 2000 Oct; 267(19):6050-9. PubMed ID: 10998066
[TBL] [Abstract][Full Text] [Related]
19. Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms.
Ghosh A; Murugesan G; Chen K; Zhang L; Wang Q; Febbraio M; Anselmo RM; Marchant K; Barnard J; Silverstein RL
Blood; 2011 Jun; 117(23):6355-66. PubMed ID: 21478428
[TBL] [Abstract][Full Text] [Related]
20. Hypochlorite-oxidized LDL induces intraplatelet ROS formation and surface exposure of CD40L--a prominent role of CD36.
Assinger A; Koller F; Schmid W; Zellner M; Koller E; Volf I
Atherosclerosis; 2010 Nov; 213(1):129-34. PubMed ID: 20701912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
